Permanent Representative of INSERM Transfert Initiative
Dr Thomas is a medical oncologist and former Senior Registrar at the Gustave Roussy Institute, with an MBA from the Massachusetts Institute of Technology, Dr. Thomas has been the president of Inserm Transfer Initiative (ITI), the initial investor in Aelis.
In addition, he held positions of VP Clinical Development of Ipsen pharmaceuticals, Managing director of Bioserve Ltd Consulting, VP Licensing and Medical Affairs of Genset, and CEO of Cythéris.
He was also a partner at Atlas Venture and Head of heathcare investment banking at Bryan Garnier. Dr Thomas has been on the board of more than 20 Biotech companies in EU and NA.